NovoCure Ltd. (NVCR)
Market Closed
3 Jun, 20:00
$
16. 15
+0.33
+2.09%
$
1.97B Market Cap
- P/E Ratio
- Div Yield
1,692,915 Volume
-2.03 Eps
$ 15.82
Previous Close 
Want to track NVCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NovoCure Ltd. (NVCR) Statistics
Valuation metrics
Market Cap 1.97B
Enterprise value 1.88B
Trailing P/E (ttm) -14.72
Forward P/E -15.33
PEG ratio -0.15
Price/Sales (ttm) 3.08
Price/Book (mrq) 6.29
Enterprise Value/Revenue 2.79
Enterprise Value/EBITDA -11.33
Overview
Shares outstanding 115.82M
Float 95.36M
Shares short 6.97M
% Held by insiders 0.1%
% Held by institutions 0.88%
Average volume (10 days) 1.35M
Average volume (90 days) 1.68M
Price summary
52-Week low 9.82
52-Week high 19.25
Beta 0.9
50-Day moving average 13.47
200-Day moving average 12.85
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.26%
Operating margin -0.39%
Operational effectiveness
Return on assets -0.11%
Return on equity -0.5%
Income Statement
Revenue (ttm) 674.41M
Revenue per share (ttm) 6
Quarterly revenue growth (yoy) 0.12%
Gross profit (ttm) 508.84M
EBITDA -166.22M
Net income to common (ttm) -173.05M
Diluted EPS (ttm) -1.53
Quarterly earnings growth (yoy) 0.12%
Balance Sheet
Total cash (mrq) 432M
Total cash per share (mrq) 3.73
Total debt (mrq) 234.94M
Total Debt/Equity (mrq) 71.04
Current ratio (mrq) 2.9%
Book value per share (mrq) 2.85
Cash Flow
Cash flow statement -26.88M
Levered free cash flow (LFCF) 5.08M
